These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19623590)

  • 1. Reversible cell-specific drug delivery with aptamer-functionalized liposomes.
    Cao Z; Tong R; Mishra A; Xu W; Wong GC; Cheng J; Lu Y
    Angew Chem Int Ed Engl; 2009; 48(35):6494-8. PubMed ID: 19623590
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation.
    Gao L; Cui Y; He Q; Yang Y; Fei J; Li J
    Chemistry; 2011 Nov; 17(47):13170-4. PubMed ID: 22012586
    [No Abstract]   [Full Text] [Related]  

  • 3. A liposome-based nanostructure for aptamer directed delivery.
    Kang H; O'Donoghue MB; Liu H; Tan W
    Chem Commun (Camb); 2010 Jan; 46(2):249-51. PubMed ID: 20024341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates.
    Zhang L; Radovic-Moreno AF; Alexis F; Gu FX; Basto PA; Bagalkot V; Jon S; Langer RS; Farokhzad OC
    ChemMedChem; 2007 Sep; 2(9):1268-71. PubMed ID: 17600796
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.
    Bagalkot V; Farokhzad OC; Langer R; Jon S
    Angew Chem Int Ed Engl; 2006 Dec; 45(48):8149-52. PubMed ID: 17099918
    [No Abstract]   [Full Text] [Related]  

  • 7. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
    Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
    J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin.
    Moreno D; Zalba S; Colom H; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Sci; 2009 Jun; 37(3-4):341-50. PubMed ID: 19491025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of cisplatin-impregnated coral hydroxyapatite drug delivery system].
    Yang JC; Yin QS; Lin J; Huang HY; Ding HW; Zhang Y; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):283-5. PubMed ID: 17425972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
    Taghdisi SM; Lavaee P; Ramezani M; Abnous K
    Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-functionalized liposomes for targeted cancer therapy.
    Moosavian SA; Sahebkar A
    Cancer Lett; 2019 Apr; 448():144-154. PubMed ID: 30763718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells.
    Ringhieri P; Pannunzio A; Boccarelli A; Morelli G; Coluccia M; Tesauro D
    J Liposome Res; 2016 Dec; 26(4):307-12. PubMed ID: 26850783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance.
    Song H; Li W; Qi R; Yan L; Jing X; Zheng M; Xiao H
    Chem Commun (Camb); 2015 Jul; 51(57):11493-5. PubMed ID: 26094840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabazitaxel liposomes with aptamer modification enhance tumor‑targeting efficacy in nude mice.
    Cheng Y; Ou Z; Li Q; Yang J; Hu M; Zhou Y; Zhuang X; Zhang ZJ; Guan S
    Mol Med Rep; 2019 Jan; 19(1):490-498. PubMed ID: 30483775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes for drug delivery to mitochondria.
    Boddapati SV; D'Souza GG; Weissig V
    Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-functionalized hydrogel as effective anti-cancer drugs delivery agents.
    Wang Z; Xia J; Cai F; Zhang F; Yang M; Bi S; Gui R; Li Y; Xia Y
    Colloids Surf B Biointerfaces; 2015 Oct; 134():40-6. PubMed ID: 26142627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A liposomal delivery vehicle for the anticancer agent gossypol.
    Zhai G; Wu J; Zhao X; Yu B; Li H; Lu Y; Ye W; Lin YC; Lee RJ
    Anticancer Res; 2008; 28(5A):2801-5. PubMed ID: 19035313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and in vitro tumor cells selectivity of sterically stabilized immunoliposomal peptides in bee venom].
    Hu HY; Chen DW; Liu YF; Qiao MX; Zhao XL
    Yao Xue Xue Bao; 2007 Nov; 42(11):1201-5. PubMed ID: 18300479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.